Global Rapid Infuser Market: An Overview

The global rapid infuser market is witnessing significant growth due to the increasing number of traumatic injuries and rising incidences of hemorrhagic shock. Rapid infusion devices help in fast administration of large volumes of intravenous fluids during surgeries or trauma care situations, providing medication to critically ill patients suffering from blood loss.

Market Analysis

The global rapid infuser market size was valued at US$ 10. 92 Million in 2024 and is expected to reach US$ 23. 85 Million by 2031, growing at a compound annual growth rate (CAGR) of 4.8% from 2024 to 2031, according to a new report published by Coherent Market Insights.

The growing demand for effective trauma and emergency care, coupled with advancements in technology, is driving the growth of the rapid infuser market.

Portable Rapid Infuser Devices

Manufacturers are developing portable and lightweight rapid infusion devices that can be easily carried and used during emergency situations. For instance, in 2021, Freeman Technology launched portable and lightweight Languard RF1 and RF3 rapid infusion devices for administering large volumes of fluids during surgery and trauma, contributing towards the growth of the market.

Pre-hospital Care

Increasing demand for high-quality pre-hospital care is also driving the growth of the rapid infuser market. Pre-hospital rapid infusion helps stabilize patients with hemorrhagic shock before they reach the hospital, making it possible to treat traumatic injury patients in ambulances and emergency medical vehicles effectively.

Trauma and Emergency Care Segment

The trauma and emergency care segment accounted for the largest share of the rapid infuser market in 2024. Rapid infusers are widely used in trauma and emergency care settings to deliver intravenous fluids and blood products quickly in life-threatening situations such as severe blood loss from injuries. The growing incidence of trauma cases from accidents or injuries will drive the demand for rapid infusion devices in emergency departments and trauma centers.

Hospitals End-User Segment

Hospitals formed the largest end-user segment in the rapid infuser market in 2024. Most major surgical procedures and emergency care take place in hospitals. The growing patient volume and investments in hospital infrastructure in developing countries are fueling the demand for rapid infusion devices in hospitals. In addition, hospitals offer reimbursement for procedures using rapid infusion therapy, encouraging their adoption.

Key Players in the Rapid Infuser Market

Some of the key players operating in the rapid infuser market include Belmont Medical Technologies, Stryker Corporation, ICU Medical, Inc., Fresenius Kabi, ZOLL Medical Corporation, 410 Medical, Ace-medical, Biegler GmbH, Terumo Corporation, Teleflex Incorporated, BD, Smission-Cartledge Biomedical, 3M Healthcare, and Shenzhen Keborui Electronics Co., Ltd.

Respiratory Care Market

The respiratory care market is estimated to be valued at USD 25.95 Bn in 2024 and is expected to reach USD 49.84 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 9.8% from 2024 to 2031.

DNA Test Kits Market

The DNA test kits market is estimated to be valued at USD 1.86 Bn in 2024 and is expected to reach USD 5.40 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 16.4% from 2024 to 2031.

Smart Pacifier Market

The smart pacifier market is estimated to be valued at USD 442.3 Mn in 2024 and is expected to reach USD 640.2 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 5.4% from 2024 to 2031.

Medical Headwalls Market

The global medical headwalls market is estimated to be valued at USD 952.9 Mn in 2024 and is expected to reach USD 1,389.8 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 5.5% from 2024 to 2031.

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We create value for clients through our highly reliable and accurate reports and offer insights in various sectors post-COVID-19, delivering measurable, sustainable results for our clients.

Originally Post From https://www.investorsobserver.com/news/qm-pr/7187759187575860

Rapid Infuser Market Forecast: $1,109 Million by 2031